167 related articles for article (PubMed ID: 26577811)
1. Endothelial precursor cell-based therapy to target the pathologic angiogenesis and compensate tumor hypoxia.
Collet G; Szade K; Nowak W; Klimkiewicz K; El Hafny-Rahbi B; Szczepanek K; Sugiyama D; Weglarczyk K; Foucault-Collet A; Guichard A; Mazan A; Nadim M; Fasani F; Lamerant-Fayel N; Grillon C; Petoud S; Beloeil JC; Jozkowicz A; Dulak J; Kieda C
Cancer Lett; 2016 Jan; 370(2):345-57. PubMed ID: 26577811
[TBL] [Abstract][Full Text] [Related]
2. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.
Li B; Sharpe EE; Maupin AB; Teleron AA; Pyle AL; Carmeliet P; Young PP
FASEB J; 2006 Jul; 20(9):1495-7. PubMed ID: 16754748
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation.
Collet G; Skrzypek K; Grillon C; Matejuk A; El Hafni-Rahbi B; Lamerant-Fayel N; Kieda C
Vascul Pharmacol; 2012; 56(5-6):252-61. PubMed ID: 22446152
[TBL] [Abstract][Full Text] [Related]
4. BMP9 Induces Cord Blood-Derived Endothelial Progenitor Cell Differentiation and Ischemic Neovascularization via ALK1.
Kim J; Kim M; Jeong Y; Lee WB; Park H; Kwon JY; Kim YM; Hwang D; Kwon YG
Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2020-31. PubMed ID: 26229139
[TBL] [Abstract][Full Text] [Related]
5. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
6. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
7. Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis.
Kanzler I; Tuchscheerer N; Steffens G; Simsekyilmaz S; Konschalla S; Kroh A; Simons D; Asare Y; Schober A; Bucala R; Weber C; Bernhagen J; Liehn EA
Basic Res Cardiol; 2013 Jan; 108(1):310. PubMed ID: 23184390
[TBL] [Abstract][Full Text] [Related]
8. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
9. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
10. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of siRNA targeting HIF-1alpha on differentiation of peripheral blood endothelial progenitor cells].
Jiang M; Wang CQ; Wang BY; Huang DJ
Ai Zheng; 2005 Nov; 24(11):1293-300. PubMed ID: 16552951
[TBL] [Abstract][Full Text] [Related]
13. Targeting endothelial progenitor cells in cancer as a novel biomarker and anti-angiogenic therapy.
Ammendola M; Leporini C; Luposella M; Sacco R; Sammarco G; Russo E; Patruno R; De Sarro G; Ranieri G
Curr Stem Cell Res Ther; 2015; 10(2):181-7. PubMed ID: 25429701
[TBL] [Abstract][Full Text] [Related]
14. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Saleh M; Stacker SA; Wilks AF
Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor--immunotoxin target gene.
Jin N; Chen W; Blazar BR; Ramakrishnan S; Vallera DA
Hum Gene Ther; 2002 Mar; 13(4):497-508. PubMed ID: 11874628
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.
Collet G; Lamerant-Fayel N; Tertil M; El Hafny-Rahbi B; Stepniewski J; Guichard A; Foucault-Collet A; Klimkiewicz K; Petoud S; Matejuk A; Grillon C; Jozkowicz A; Dulak J; Kieda C
Mol Cancer Ther; 2014 Jan; 13(1):165-78. PubMed ID: 24170768
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
